Navigation Links
Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits
Date:12/11/2007

GAITHERSBURG, Md., Dec. 11 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. has initiated manufacturing of PC Detect(SM) kits, the Company's diagnostic test for prostate cancer, under GMP conditions. Data on the performance of the PC Detect(SM) kit will be included in a Premarket Approval (PMA) application for this diagnostic test to be filed with the U.S. Food and Drug Administration in early 2008. To date, PC Detect(SM) has demonstrated sensitivity and specificity of greater than 90 percent in identifying men with prostate cancer. PC Detect(SM) was initially launched in May 2007 as a laboratory service by Panacea Laboratories, a division of Panacea Pharmaceuticals; Panacea Laboratories is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. FDA approval of a PC Detect(SM) kit will facilitate the wider distribution and availability of this diagnostic test through clinical laboratories and hospitals across the U.S. The Company is seeking to identify one or more partner companies to facilitate the distribution and commercialization of the PC Detect(SM) kit in the U.S. and other countries.

The PC Detect(SM) kit, as with the PC Detect(SM) laboratory service, requires a small serum sample and measures blood levels of Human Aspartyl (Asparaginyl) Beta-Hydroxylase (HAAH), a cancer biomarker. HAAH has been established as an excellent biomarker for many types of cancer, including prostate cancer. The protein is typically undetectable in sera from cancer-free individuals, thus, an elevated serum protein level of HAAH is highly diagnostic for cancer. PC Detect(SM) is recommended as an adjunct to the prostate specific antigen (PSA) test and the digital rectal examination (DRE), the currently recommended prostate cancer screening methods. The addition of PC Detect(SM) to the current screening methods should improve the diagnosis of prostate cancer among men with prostate specific antigen (PSA) values below
'/>"/>

SOURCE Panacea Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
2. Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... access to healthcareDANBURY, Conn., May 28 ... opening of a new, expanded clinic in Danbury to ... a time when demand for such services is higher ... at 76 West Street, is a partnership between AmeriCares ...
... and MELVILLE, N.Y., May 28 Bayer HealthCare LLC., ... Pharmaceuticals, Inc. (Nasdaq: OSIP ) and Roche ... examining Nexavar(R) (sorafenib) tablets in combination with Tarceva(R) (erlotinib) ... with advanced hepatocellular carcinoma (HCC), or primary liver cancer.The ...
... Tenn., May 28 Dalcon Communications Systems, Inc. ... the Dalcon Communications Manager-Health Care Edition as a ... Award."Dalcon has proven they are committed to quality ... marketplace. Unified Communications is pleased to grant ...
... Call Your Representatives, Says LTC Expert Denise GottKIRKLAND, Wash., ... affordable, accessible, high-quality health care for all Americans, "There,s ... care gap," says Denise Gott. "Only about 9 million ... long term care insurance. And among those at greatest ...
... company to sign on to Alliance,s Guidelines , ... Gaithersburg, Md. and ... leading food and facilities management services company and a leader in student ... the Alliance for a Healthier Generation,s School Beverage and Competitive Food Guidelines. ...
... Sodexo is first food service company to sign on ... Sodexo, a leading food and facilities management services ... the first food service provider to sign on to ... Competitive Food Guidelines. The Alliance for a Healthier Generation, ...
Cached Medicine News:Health News:AmeriCares and Boehringer Ingelheim Open New, Expanded Free Clinic to Help Families Hit Hardest by Economic Hardship 2Health News:AmeriCares and Boehringer Ingelheim Open New, Expanded Free Clinic to Help Families Hit Hardest by Economic Hardship 3Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 2Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 3Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 4Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 5Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 6Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 7Health News:Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer 8Health News:Dalcon Receives Unified Communications Magazine's Product of the Year Award 2Health News:Dalcon Receives Unified Communications Magazine's Product of the Year Award 3Health News:Voters Urged to Support Budding Moves to Include Long Term Care in National Health Reform 2Health News:Voters Urged to Support Budding Moves to Include Long Term Care in National Health Reform 3Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 2Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 3Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 4Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 2Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 3Health News:Alliance for a Healthier Generation Applauds Sodexo for Their Pledge to Fight Childhood Obesity 4
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)...  Now available for sale, The Armor1 Ankle Roll Guard is ... sprains by cushioning the ankle from an inversion or ... outside of any shoe type and allows the user ... protection against sprains. With customers in physical therapy, podiatry, ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... and NUREMBERG, Germany, April 13, 2012 ... of mobile C-arms presents its award-winning product portfolio ... Together with Xograph ( http://www.xograph.com ), its UK ... vascular specialists, interventional radiologists and cardiologists to provide ...
... ("Unilife" or "Company") (NASDAQ: UNIS ;  ASX: UNS) announced ... fiscal 2012 third quarter ended March 31, 2012 after market trading ... scheduled a conference call for 4:30 p.m. U.S. EDT on Thursday, ... AM AEST) , to review the Company,s financial results, market ...
Cached Medicine Technology:CX 2012: Elevating the Boundaries of Interventional Imaging with Mobile C-arms 2Unilife Corporation to Announce Financial Results for Fiscal 2012 Third Quarter on Thursday, April 26, 2012 2Unilife Corporation to Announce Financial Results for Fiscal 2012 Third Quarter on Thursday, April 26, 2012 3
The precise, fully reusable R-100 Pullback Device is an invaluable tool during plaque volumetric analysis....
... the GE Innova 2100IQ: See the finest ... Place interventional devices. Its all enabled by ... that helps deliver excellent image quality and ... family systems installed worldwide, more physicians rely ...
... imola is a bench-top fully automated ... a host of features usually only ... imola has the capacity to perform ... plus ISEs, and offers primary tube ...
... a fully automated clinical chemistry analyser. It ... offering many features only seen previously on ... cuvettes, on board reagent refrigeration and barcoding ... analyser can accommodate up to 40 reagent ...
Medicine Products: